Beneficial Effects of a Novel Inhibitor of Platelet-Derived Growth Factor Receptor Autophosphorylation in the Rat with Mesangial Proliferative Glomerulonephritis - evidence for a model of intramolecular allosteric activation

By Yagi M.   Kato S.   Kobayashi Y.   Kobayashi N.   Iinuma N.   Nakamura K.   Kubo K.   Ohyama S.-I.   Murooka H.   Shimizu T.   Nishitoba T.   Osawa T.   Nagano N.  

General Pharmacology, Vol. 31, Iss. 5, 1998-11 ,pp. : 765-773

Elsevier

Access to resources Recommend Favorite

Thromboxane A 2 induces cell signaling but requires platelet-derived growth factor to act as a mitogen

By Grosser T.   Zucker T.-P.   Weber A.-A.   Schulte K.   Sachinidis A.   Vetter H.   Schror K.  

European Journal of Pharmacology, Vol. 319, Iss. 2, 1997-01 ,pp. : 327-332

Elsevier

Access to resources Recommend Favorite

Tyr⁷⁴⁰ and Tyr⁷⁵¹ residues of platelet-derived growth factor beta receptor are responsible for the redox regulation of phosphatase and tensin homolog in the cells stimulated with platelet-derived growth factor

By Kim Inyoung   Han Seong-Jeong   Kim Yujeong   Ahn Younghee   Chay Kee-Oh   Lee Seung-Rock  

Redox Report, Vol. 16, Iss. 4, 2011-07 ,pp. : 181-186

Maney Publishing

Access to resources Recommend Favorite

Pyrrolo[3,4-c]- -carboline-diones as a novel class of inhibitors of the platelet-derived growth factor receptor kinase

By Teller S.   Eluwa S.   Koller M.   Uecker A.   Beckers T.   Baasner S.   Bohmer F.-D.   Mahboobi S.  

European Journal of Medicinal Chemistry, Vol. 35, Iss. 4, 2000-04 ,pp. : 413-427

Elsevier

Access to resources Recommend Favorite

Endothelin ET A receptor antagonist reverses the inhibitory effect of platelet-derived growth factor on cytokine-induced nitric oxide production

By Hirahashi J.   Nakaki T.   Hishikawa K.   Marumo T.   Hayashi M.   Saruta T.  

European Journal of Pharmacology, Vol. 365, Iss. 1, 1999-01 ,pp. : 119-123

Elsevier

Access to resources Recommend Favorite